Bristol Medical School, University of Bristol, Bristol, UK; Bristol Trials Centre (BRTC), University of Bristol, Bristol, UK.
Bristol Urological Institute, Level 3, Learning and Research Building, North Bristol NHS Trust, Southmead Hospital, Bristol, UK.
Eur Urol Focus. 2022 Sep;8(5):1331-1339. doi: 10.1016/j.euf.2021.11.010. Epub 2021 Dec 16.
Identifying men whose lower urinary tract symptoms (LUTS) may benefit from surgery is challenging.
To identify routine diagnostic and urodynamic measures associated with treatment decision-making, and outcome, in exploratory analyses of the UPSTREAM trial.
DESIGN, SETTING, AND PARTICIPANTS: A randomised controlled trial was conducted including 820 men, considering surgery for LUTS, across 26 hospitals in England (ISCTRN56164274).
Men were randomised to a routine care (RC) diagnostic pathway (n = 393) or a pathway that included urodynamics (UDS) in addition to RC (n = 427).
Men underwent uroflowmetry and completed symptom questionnaires, at baseline and 18 mo after randomisation. Regression models identified baseline clinical and symptom measures that predicted recommendation for surgery and/or surgical outcome (measured by the International Prostate Symptom Score [IPSS]). We explored the association between UDS and surgical outcome in subgroups defined by routine measures.
The recommendation for surgery could be predicted successfully in the RC and UDS groups (area under the receiver operating characteristic curve 0.78), with maximum flow rate (Q) and age predictors in both groups. Surgery was more beneficial in those with higher symptom scores (eg, IPSS >16), age <74 yr, Q <9.8 ml/s, bladder outlet obstruction index >47.6, and bladder contractility index >123.0. In the UDS group, urodynamic measures were more strongly predictive of surgical outcome for those with Q >15, although patient-reported outcomes were also more predictive in this subgroup.
Treatment decisions were informed with UDS, when available, but without evidence of change in the decisions reached. Despite the small group sizes, exploratory analyses suggest that selective use of UDS could detect obstructive pathology, missed by routine measures, in certain subgroups.
Baseline clinical and symptom measurements were able to predict treatment decisions. The addition of urodynamic test results, while useful, did not generally lead to better surgical decisions and outcomes over routine tests alone.
识别可能从手术中获益的下尿路症状(LUTS)男性具有挑战性。
在 UPSTREAM 试验的探索性分析中,确定与治疗决策和结果相关的常规诊断和尿动力学措施。
设计、地点和参与者:一项随机对照试验包括 820 名男性,他们在英格兰的 26 家医院考虑接受 LUTS 手术(ISCTRN56164274)。男性被随机分配到常规护理(RC)诊断途径(n=393)或包括 RC 加尿动力学(UDS)的途径(n=427)。
男性在基线和随机分组后 18 个月时接受尿流率测量和症状问卷。回归模型确定了预测手术建议和/或手术结果的基线临床和症状措施(通过国际前列腺症状评分[IPSS]测量)。我们在由常规措施定义的亚组中探索了 UDS 与手术结果之间的关联。
RC 和 UDS 组可以成功预测手术建议(接受者操作特征曲线下面积 0.78),两组的最大流量率(Q)和年龄预测因子。对于那些具有更高症状评分(例如,IPSS>16)、年龄<74 岁、Q<9.8ml/s、膀胱出口梗阻指数>47.6 和膀胱收缩力指数>123.0 的患者,手术更有益。在 UDS 组中,对于 Q>15 的患者,尿动力学测量值对手术结果的预测作用更强,尽管在该亚组中,患者报告的结果也更具预测性。
当有 UDS 时,可以使用 UDS 为治疗决策提供信息,但没有证据表明所做的决策发生了变化。尽管小组规模较小,但探索性分析表明,选择性使用 UDS 可以在某些亚组中检测到常规测量遗漏的阻塞性病变。
基线临床和症状测量能够预测治疗决策。虽然尿动力学测试结果有用,但通常不会导致比单独常规测试更好的手术决策和结果。